Chris McCabe

BA (Hons), MSc, PhD
Professor of Economics, QUB

Dr. Christopher McCabe is Professor of Health Economics at Queen’s University Belfast (QUB) and the Senior Scientific Advisor for the Institute of Health Economics (IHE) HTIP Program.  Dr. McCabe served as the CEO and Executive Director for the IHE from 2017 to 2022. On September 1, 2022, he began a new post as Professor of Health Economics at Queen’s University Belfast (QUB)  where he will be part of QUB’s contribution to the Belfast City Region Deal supporting economic development in the life sciences sector. He will be cross-appointed between the Centre for Public Health in the School of Medicine, Dentistry and Biomedical Sciences and Queen’s Management School. He will continue his research developing early Health Technology Assessment for life sciences commercialization, and multi-sectoral collaboration for pandemic planning and policy evaluation, as well as providing health economics input to the Institute of Research Excellence for Advanced Clinical Healthcare (iREACH) and Global Innovation Institute. The IHE is very pleased that Dr. McCabe will continue to contribute to the Institute’s work program as a Senior Scientific Advisor to the Health Technology Innovation Platform.

Dr. McCabe has worked more than 25 years as a health economist both in the UK and Canada. During his career he has held Full Professorships at the Universities of Sheffield, Warwick and Leeds and the University of Alberta, where he was appointed Capital Health Endowed Research Chair at the University of Alberta, leading two Genome Canada research groups focused on the evaluation, adoption and implementation of Precision Medicine technologies. In 2017 he was appointed as CEO and Executive Director of the Institute of Health Economics and during his time as CEO, the Institute grew and diversified beyond its core activities in health technology assessment, to become recognized as a premier health and economics research organization, providing support to small, medium and multi-national enterprises in the Canadian life sciences sector, provincial and federal governments, and working with academics in the majority of the U15 universities.